{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T18:20:28Z","timestamp":1774981228288,"version":"3.50.1"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,1]]},"abstract":"<jats:sec>\n            <jats:title>Background\/Aim<\/jats:title>\n            <jats:p>Systematic reporting using qualitative evaluation of PET\/computed tomography (CT) results has been demonstrated to be very accurate and reproducible in posttherapy assessment of lung cancer (so-called Hopkins criteria). Our aim was to test, in a different cohort of patients, the Hopkins criteria for assessment of therapeutic response in lung cancer and to compare the results with those obtained using a semi-quantitative evaluation of uptake.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This is a retrospective study. A total of 85 patients with known lung cancer who underwent fluorine-18 fluorodeoxyglucose PET\/CT assessment within 24\u2009weeks (mean 7.9\u2009weeks) of completion of treatment were included. Treatments included surgical resection, chemotherapy, radiation therapy, immunotherapy or combinations thereof. PET\/CT interpretation was done by two nuclear medicine physicians, and discrepancies were resolved by a third interpreter. Studies were scored both according to the Hopkins criteria using qualitative assessment of tracer uptake for the primary tumour, locoregional disease in the mediastinum and distant metastatic sites and by applying the same five-point score using a semi-quantitative measure, maximum standardized uptake value. Overall scores of 1, 2 and 3 were considered negative for residual disease, while scores of 4 and 5 were considered positive. Patients were followed up for a median of 18.5\u2009months (range 2\u2013139\u2009months). Kaplan\u2013Meier plots with a Mantel-Cox log-rank test were performed, considering death as the endpoint. Inter-reader variability was assessed using percent agreement and kappa statistics.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The Cohen \u03ba coefficient analysis showed substantial agreement between the two interpreters on the five-point Hopkins criteria scoring, with a \u03ba of 0.73. There was almost perfect agreement between the interpreters with respect to classification as positive or negative according to the Hopkins criteria, with a \u03ba of 0.89. The sensitivity, specificity, positive predictive value, negative predictive value and accuracy of the Hopkins criteria were 88.5% [95% confidence interval (CI) 80.6\u201396.5%), 79.2% (95% CI 63.2\u201395.1%), 91.5% (95% CI 84.4\u201398.6%), 73.1% (95% CI 61.8\u201384.4%) and 85.9% (95% CI 78.5\u201393.3%), respectively. There was almost perfect agreement between the qualitative and semi-quantitative scoring with a \u03ba of 0.87, with sensitivity, specificity, positive predictive value, negative predictive value and accuracy of the semi-quantitative Hopkin\u2019s criteria of 86.9% (95% CI 78.4\u201395.4%), 79.2% (95% CI 62.9\u201395.4%), 91.4% (95% CI 84.2\u201398.6%), 70.4% (95% CI 58.6\u201382.1%) and 84.7% (95% CI 80.8\u201392.4%), respectively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The use of Hopkins criteria for posttherapy assessment in patients with lung cancer represents an easy and reproducible method with substantial to almost perfect interobserver agreement and high positive predictive value and accuracy; moreover, it is easily understood by referring physicians. Additionally, there was no significant difference when applying a semi-quantitative measure to the same five-point score.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mnm.0000000000001114","type":"journal-article","created":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T16:03:06Z","timestamp":1575475386000},"page":"18-25","source":"Crossref","is-referenced-by-count":6,"title":["Revalidation of PET\/computed tomography criteria (Hopkins criteria) for the assessment of therapeutic response in lung cancer patients: inter-reader reliability, accuracy and survival outcomes"],"prefix":"10.1097","volume":"41","author":[{"given":"Khulood Al","family":"Riyami","sequence":"first","affiliation":[{"name":"Institute of Nuclear Medicine, University College Hospital London, UK"},{"name":"Department of radiology and molecular imaging, Sultan Qaboos University Hospital, Oman"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noor Al","family":"Nuaimi","sequence":"additional","affiliation":[{"name":"Institute of Nuclear Medicine, University College Hospital London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruta","family":"Kliokyte","sequence":"additional","affiliation":[{"name":"Centre of Radiology and Nuclear Medicine, Vilnius University Santaros Clinics, Lithuania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Voo","sequence":"additional","affiliation":[{"name":"Institute of Nuclear Medicine, University College Hospital London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Thornton","sequence":"additional","affiliation":[{"name":"Institute of Nuclear Medicine, University College Hospital London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamshed","family":"Bomanji","sequence":"additional","affiliation":[{"name":"Institute of Nuclear Medicine, University College Hospital London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Fraioli","sequence":"additional","affiliation":[{"name":"Institute of Nuclear Medicine, University College Hospital London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230917","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"R2-20230917","article-title":"Facts & figures 2019.","year":"2019","journal-title":"Am Cancer Soc"},{"key":"R4-20230917","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1440-1843.2006.00956.x","article-title":"Follow up and surveillance of the patient with lung cancer: what do you do after surgery?","volume":"12","author":"Alberts","year":"2007","journal-title":"Respirology"},{"key":"R5-20230917","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.athoracsur.2006.08.046","article-title":"Survival after recurrent nonsmall-cell lung cancer after complete pulmonary resection.","volume":"83","author":"Sugimura","year":"2007","journal-title":"Ann Thorac Surg"},{"key":"R6-20230917","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2967\/jnumed.115.165480","article-title":"18F-FDG PET\/CT: therapy response assessment interpretation (hopkins criteria) and survival outcomes in lung cancer patients.","volume":"57","author":"Sheikhbahaei","year":"2016","journal-title":"J Nucl Med"},{"key":"R7-20230917","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/S0140-6736(02)08352-6","article-title":"Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial.","volume":"359","author":"van Tinteren","year":"2002","journal-title":"Lancet"},{"key":"R8-20230917","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa0900043","article-title":"Preoperative staging of lung cancer with combined PET-CT.","volume":"361","author":"Fischer","year":"2009","journal-title":"N Engl J Med"},{"key":"R9-20230917","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cpet.2014.09.002","article-title":"Assessment of treatment response using PET.","volume":"10","author":"Basu","year":"2015","journal-title":"PET Clin"},{"issue":"Suppl 1","key":"R10-20230917","doi-asserted-by":"crossref","first-page":"122S","DOI":"10.2967\/jnumed.108.057307","article-title":"From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors.","volume":"50","author":"Wahl","year":"2009","journal-title":"J Nucl Med"},{"key":"R11-20230917","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1148\/radiol.2016142043","article-title":"Practical PERCIST: a simplified guide to PET response criteria in solid tumors 1.0.","volume":"280","author":"O","year":"2016","journal-title":"Radiology"},{"key":"R12-20230917","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00259-017-3690-8","article-title":"FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas.","volume":"44","author":"Barrington","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R13-20230917","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.3324\/haematol.2013.103218","article-title":"The predictive role of interim positron emission tomography for hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the deauville five-point scale.","volume":"99","author":"Gallamini","year":"2014","journal-title":"Haematologica"},{"key":"R14-20230917","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1200\/JCO.2003.07.054","article-title":"Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancer.","volume":"21","author":"Mac Manus","year":"2003","journal-title":"J Clin Oncol"},{"key":"R15-20230917","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.lungcan.2004.11.024","article-title":"Metabolic (FDG-PET) response after radical radiotherapy\/chemoradiotherapy for non-small cell lung cancer correlates with patterns of failure.","volume":"49","author":"Mac Manus","year":"2005","journal-title":"Lung Cancer"},{"key":"R16-20230917","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1023\/A:1008437915860","article-title":"Potential use of FDG-PET scan after induction chemotherapy in surgically staged iiia-N2 non-small-cell lung cancer: a prospective pilot study. The Leuven lung cancer group.","volume":"9","author":"Vansteenkiste","year":"1998","journal-title":"Ann Oncol"},{"key":"R17-20230917","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/s00259-012-2321-7","article-title":"Prognostic implications of volume-based measurements on FDG PET\/CT in stage III non-small-cell lung cancer after induction chemotherapy.","volume":"40","author":"Soussan","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R18-20230917","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1200\/JCO.2003.12.004","article-title":"Positron emission tomography in non-small-cell lung cancer: prediction of response to chemotherapy by quantitative assessment of glucose use.","volume":"21","author":"Weber","year":"2003","journal-title":"J Clin Oncol"},{"key":"R19-20230917","first-page":"1356","article-title":"Factors that influence standard uptake values in FDG PET\/CT.","volume":"55","author":"Plaxton","year":"2014","journal-title":"J Nucl Med"},{"key":"R20-20230917","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.radphyschem.2018.01.019","article-title":"Reliability of standardized uptake value normalized to lean body mass using the liver as a reference organ, in contrast-enhanced 18F-FDG PET\/CT imaging.","volume":"147","author":"Azmi","year":"2018","journal-title":"Radiat Phys Chem"}],"container-title":["Nuclear Medicine Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MNM.0000000000001114","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T05:00:44Z","timestamp":1694926844000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MNM.0000000000001114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/mnm.0000000000001114","relation":{},"ISSN":["0143-3636"],"issn-type":[{"value":"0143-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]}}}